Therapeutic Potential of Combined Treatments Recent advancements in multiple sclerosis (MS) treatment emphasize the significance of combining therapeutics to enhance […]
Study Overview The research investigates how monitoring neurofilament light chain (NfL) levels can refine treatment strategies in individuals with relapsing
Study Overview This research investigates the synergistic effects of clemastine fumarate, an antihistamine, and selenomethionine, an amino acid with antioxidant
Study Overview This study investigates the effects of Interferon-γ (IFN-γ) on dendritic cells, which are critical components of the immune
Study Overview This study presents two case reports examining the efficacy of cladribine in patients diagnosed with chronic inflammatory demyelinating
Background and Rationale Multiple sclerosis (MS) is a progressive neurological disease characterized by the degeneration of myelin, the protective sheath
Mechanisms of Action The therapeutic effects of combined clemastine fumarate and selenomethionine in promoting remyelination are rooted in their ability
Case Presentation In this report, we discuss a unique patient, a 32-year-old female who exhibited symptoms characteristic of Guillain-Barré Syndrome
Study Overview The study centers on the exploration of acute-onset chronic inflammatory demyelinating polyneuropathy (AOCIDP), particularly its presentation as recurrent
Study Overview The clinical trial investigated the use of hyaluronidase-facilitated subcutaneous immunoglobulin (Ig) 10% as a long-term maintenance therapy for
